BioPharma Expo OsakaBioPharma Expo

BioPharma Expo Osaka covers R&D technologies, manufacturing technologies, and contract services, attracting visitors, exhibitors, and professionals from the global biopharmaceutical technology sector.

Japan has become the world's second-largest investor in biopharmaceutical R&D and ranks as the third-largest pharmaceutical and biotech market globally, following the US and China. Its R&D investment in the pharma and biotech sectors ranks second worldwide, while the global biopharmaceutical industry continues to expand rapidly.

BioPharma Expo Osaka brings together 450 global pharmaceutical companies to explore emerging trends in antibody drugs, cell therapy, and AI-driven R&D. Featuring a PMDA policy forum and a China-Japan summit, the event empowers enterprises to seize first-mover advantages in the Asian biopharmaceutical market.

In recent years, driven by Japan's aging population, market demand for related industries has been increasing annually. Concurrently, the Japanese government is actively implementing pharmaceutical market reform policies, which require strong international support to introduce new technologies and resources. Key focus areas include R&D for new drug testing, standardized practical applications of stem cell regenerative medicine and cell therapies, and safety technologies for new drug evaluation.

Juzhan has successfully organized numerous high-quality enterprises to participate multiple times! BioPharma Expo Osaka offers boundless business opportunities for merchants worldwide. (Copyright of this content belongs to Juzhan. Reproduction without permission is prohibited.)